» Articles » PMID: 38981607

Exercise As a Tool to Mitigate Metabolic Disease

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Metabolic diseases, notably obesity and type 2 diabetes (T2D), have reached alarming proportions and constitute a significant global health challenge, emphasizing the urgent need for effective preventive and therapeutic strategies. In contrast, exercise training emerges as a potent intervention, exerting numerous positive effects on metabolic health through adaptations to the metabolic tissues. Here, we reviewed the major features of our current understanding with respect to the intricate interplay between metabolic diseases and key metabolic tissues, including adipose tissue, skeletal muscle, and liver, describing some of the main underlying mechanisms driving pathogenesis, as well as the role of exercise to combat and treat obesity and metabolic disease.

Citing Articles

The dual role of feimin in metabolism and exercise.

Esteves J, Stanford K Nat Metab. 2025; 7(1):6-7.

PMID: 39747482 DOI: 10.1038/s42255-024-01173-x.

References
1.
Goossens G . The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav. 2007; 94(2):206-18. DOI: 10.1016/j.physbeh.2007.10.010. View

2.
Saltiel A, Olefsky J . Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017; 127(1):1-4. PMC: 5199709. DOI: 10.1172/JCI92035. View

3.
Gregory J, Muldowney J, Engelhardt B, Tyree R, Marks-Shulman P, Silver H . Aerobic exercise training improves hepatic and muscle insulin sensitivity, but reduces splanchnic glucose uptake in obese humans with type 2 diabetes. Nutr Diabetes. 2019; 9(1):25. PMC: 6717736. DOI: 10.1038/s41387-019-0090-0. View

4.
Hood D, Memme J, Oliveira A, Triolo M . Maintenance of Skeletal Muscle Mitochondria in Health, Exercise, and Aging. Annu Rev Physiol. 2018; 81:19-41. DOI: 10.1146/annurev-physiol-020518-114310. View

5.
Esteves J, Yonamine C, Machado U . expression and its epigenetic regulation as biomarkers for insulin resistance treatment in diabetes mellitus. Biomark Med. 2020; 14(6):413-416. DOI: 10.2217/bmm-2019-0481. View